Click here for mobile version: http://www.healthexecwire.com/releases/hewselect100914.htm
|
Greetings, Have you heard about IIR’s new event, the FDA/CMS Summit for Payers? If not, I’d like to take a few minutes to introduce you and let you know how important this meeting is, as I will be keynoting on December 11-12, 2014 at the Fairmont in Washington D.C. Based on my experiences as former CEO of Highmark, former Assistant Secretary of Defense for Health Affairs and physician, I can relate on the impact of the ACA and the significant changes it has brought about to your daily operations, including the the approval of the hepatitis C drug, Sovaldi. IIR’s FDA/CMS Summit for Payers sets the stage for health plan’s top rank to reveal their visions on key issues and current challenges so you can prioritize your 2015 goals. This is where crucial discussions and perspectives will be shared on how payers, pharma and government can work together to drive positive policy change through collaboration. I urge you to review full agenda here and save $200 by registering today at www.FDACMSSummitforPayers.com with code XP1917HEW. If you need any further information about this event, please feel free to contact the conference producer, Sakina Hussain, at (646)-895-7310 or shussain@iirusa.com. Kindest regards, Dr. William Winkenwerder Jr., M.D., MBA Former CEO, Highmark, Inc P.S. Join the event’s LinkedIn group here to stay up-to-date on the latest trends and news in the healthcare space. |
Return to HealthExecWire Archive Menu